[go: up one dir, main page]

WO2023033434A1 - Dispositif, procédé et support d'enregistrement d'aide à l'utilisation de gouttes oculaires - Google Patents

Dispositif, procédé et support d'enregistrement d'aide à l'utilisation de gouttes oculaires Download PDF

Info

Publication number
WO2023033434A1
WO2023033434A1 PCT/KR2022/012571 KR2022012571W WO2023033434A1 WO 2023033434 A1 WO2023033434 A1 WO 2023033434A1 KR 2022012571 W KR2022012571 W KR 2022012571W WO 2023033434 A1 WO2023033434 A1 WO 2023033434A1
Authority
WO
WIPO (PCT)
Prior art keywords
information
eye drop
user
eyedrop
side effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2022/012571
Other languages
English (en)
Korean (ko)
Inventor
신혜영
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Industry Academic Cooperation Foundation of Catholic University of Korea
Original Assignee
Industry Academic Cooperation Foundation of Catholic University of Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Industry Academic Cooperation Foundation of Catholic University of Korea filed Critical Industry Academic Cooperation Foundation of Catholic University of Korea
Publication of WO2023033434A1 publication Critical patent/WO2023033434A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/20—ICT specially adapted for the handling or processing of medical references relating to practices or guidelines
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H80/00—ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring

Definitions

  • the present embodiments provide an eyedrop use supporting device, method, and recording medium.
  • eye drops can cause side effects, so you should carefully check the side effects listed in the drug manual.
  • eye drops with an antihistamine component are mainly used as eye drops for conjunctivitis, which can cause side effects such as drowsiness, vomiting, and blurred vision.
  • patients who use several types of eye drops have a high risk of side effects, and it is difficult for patients to determine which type of eye drops caused side effects by themselves as they use several types of eye drops.
  • a technique for analyzing the patient's eyedrop use pattern and providing an alarm and feedback so that the patient can train the eyedrop use habit is required.
  • a technique for providing feedback is required so that the patient can appropriately respond to side effects that may occur after using eye drops.
  • an object of the present embodiments is an apparatus and method for supporting the use of eye drops by generating side effect information and use pattern information according to the use of eye drops when a user uses at least one eye drop. and a recording medium.
  • the present embodiment provides an eyedrop use support device, information for obtaining at least one eyedrop-specific eyedrop information used by a user, user symptom information, and user eyedrop-specific use information.
  • a user management unit that generates side effect information and use pattern information according to the use of eye drops using the acquisition unit and the use information for each eye drop, and generates customized information to be provided to the user based on at least one of the generated side effect information and use pattern information.
  • a notification information generation unit configured to generate notification information for improving a user's use of eye drops based on side effect information or usage pattern information.
  • the present embodiment provides a method for supporting the use of eye drops, including an information acquisition step of obtaining at least one eye drop information for each eye drop used by a user, symptom information of the user, and use information for each eye drop of the user, and using information for each eye drop.
  • a user management step of generating side effect information and usage pattern information according to the use of the eyedrops using the eyedrops, and generating customized information to be provided to the user based on at least one of the generated side effect information and usage pattern information, and side effect information or usage pattern information It is possible to provide an eyedrop use support method comprising a notification information generation step of generating notification information for improving the user's eyedrop use based on the.
  • the present embodiment provides a recording medium on which a program for executing an eyedrop use support method is recorded, wherein at least one eyedrop information for each eyedrop used by a user, symptom information of the user, and usage information for each eyedropper of the user are obtained.
  • An information acquisition function to generate side effect information and usage pattern information according to the use of eye drops using the use information for each eye drop, and generate customized information to be provided to the user based on at least one of the generated side effect information and usage pattern information
  • FIG. 1 is a diagram exemplarily illustrating a system to which an apparatus for supporting use of eye drops according to an embodiment of the present disclosure may be applied.
  • FIG. 2 is a diagram showing the configuration of an eyedrop use support device according to an embodiment of the present disclosure.
  • FIG. 3 is a flowchart illustrating an overall operation of generating customized information and notification information by the apparatus for supporting use of eye drops according to an embodiment of the present disclosure.
  • FIG. 4 is a flowchart illustrating an operation of generating and using side effect information by the apparatus for supporting use of eye drops according to an embodiment of the present disclosure.
  • FIG. 5 is a flowchart illustrating an operation of generating and using use pattern information by the apparatus for supporting use of eye drops according to an embodiment of the present disclosure.
  • FIG. 6 is a flowchart of a method for supporting use of eye drops according to an embodiment of the present disclosure.
  • FIG. 7 is a diagram conceptually illustrating the configuration of a recording medium according to an embodiment of the present disclosure.
  • the present disclosure relates to an eyedrop use support device, method, and recording medium.
  • first, second, A, B, (a), and (b) may be used in describing the components of the present disclosure. These terms are only used to distinguish the component from other components, and the nature, sequence, order, or number of the corresponding component is not limited by the term.
  • FIG. 1 is a diagram exemplarily illustrating a system to which an apparatus for supporting use of eye drops according to an embodiment of the present disclosure may be applied.
  • a system to which an apparatus 100 for supporting use of eye drops according to an embodiment of the present disclosure may be applied may be implemented by including a server 110 and a network 120 .
  • the apparatus for supporting the use of eye drops 100 is a device capable of performing the method for supporting the use of eye drops according to an embodiment of the present disclosure, and includes hardware such as an electronic device capable of executing a program, software executed by a processor, or a combination thereof. can be implemented
  • the eye drops use support device 100 when the eye drops use support device 100 is implemented as hardware, it includes a general PC such as a general desktop or laptop, and includes a smart phone, a tablet PC, a PDA (Personal Digital Assistants), and a mobile communication terminal. It may include a mobile terminal and the like.
  • a general PC such as a general desktop or laptop
  • PDA Personal Digital Assistants
  • the apparatus 100 for supporting use of eye drops may be implemented as an application capable of inputting information according to a user's manipulation and performing a method for supporting use of eye drops according to an embodiment of the present disclosure.
  • it may be an eyedrop use support application or program, but it may be widely interpreted without being limited to its name or type.
  • the server 110 may be connected to an unspecified number of clients (including the device 100) and/or other servers through the network 120. Accordingly, the server 110 may refer to a computer system that receives a request for performing a task from a client or another server and derives and provides a result of the task, or refers to computer software (server program) installed for such a computer system.
  • server program computer software
  • the server 110 may collect, store, and manage environmental data including component data, usage and dosage data, and side effect data of eye drops.
  • the server 110 may transmit corresponding data according to the request of the apparatus 100 for supporting the use of eye drops.
  • the server 110 may provide environment data to the eye drop use support device 100 through an application corresponding to the eye drop use support service.
  • the server 110 is understood as a broad concept including, in addition to the above-described server program, a series of application programs that operate on the server 110 and, in some cases, various databases built inside or outside. It should be.
  • the server 110 may refer to an aggregate of data in which data such as information or data is structured and managed for the purpose of being used by a server or other device, and may also refer to a storage medium for storing such an aggregate of data. there is.
  • the server 110 may include a plurality of databases classified according to a data structure method, management method, and type.
  • the server 110 may include a database management system (DBMS), which is software that allows information or data to be added, modified, deleted, and the like.
  • DBMS database management system
  • the network 120 is a network that connects the eyedrop use support device 100 and the server 110, and may be a closed network such as a local area network (LAN) or a wide area network (WAN). It may be an open network such as the Internet.
  • the Internet refers to the TCP/IP protocol and various services existing in its upper layer, namely HTTP (HyperText Transfer Protocol), Telnet, FTP (File Transfer Protocol), DNS (Domain Name System), SMTP (Simple Mail Transfer Protocol), It refers to a worldwide open computer network structure that provides Simple Network Management Protocol (SNMP), Network File Service (NFS), and Network Information Service (NIS).
  • SNMP Simple Network Management Protocol
  • NFS Network File Service
  • NIS Network Information Service
  • FIG. 2 is a diagram showing the configuration of an eyedrop use support device according to an embodiment of the present disclosure.
  • the apparatus 100 for supporting use of eye drops includes information for obtaining at least one eye drop information for each eye drop used by a user, symptom information of the user, and information for using each eye drop of the user.
  • the acquisition unit 210 generates side effect information and usage pattern information according to the use of the eye drops using the eye drop usage information, and generates customized information to be provided to the user based on at least one of the generated side effect information and usage pattern information.
  • an eyedrop use support device 100 including a user management unit 220 and a notification information generation unit 230 that generates notification information for improving a user's eyedrop use based on side effect information or usage pattern information.
  • the information acquisition unit 210 may obtain at least one eyedrop information for each eyedrop used by the user, symptom information of the user, and usage information for each eyedropper of the user.
  • the information acquisition unit 210 may acquire information on eye drops for each eye drop for at least one eye drop used by the user.
  • the information acquisition unit 210 may receive eye drop name information and eye drop number information from a user and obtain eye drop information for each eye drop.
  • the information acquisition unit 210 may obtain eyedrop-specific eyedropper information by automatically extracting eyedrop name information and eyedrop number information from the user's medical record received from the server.
  • the information acquisition unit 210 may acquire information about the ingredients, dosage and usage, effects, side effects, interactions, etc. of the eye drops received from the server 110 as eye drop information for each eye drop based on the eye drop name information.
  • the information acquiring unit 210 may obtain user symptom information regarding a symptom that occurs after the user uses eyedrops.
  • the information obtaining unit 210 may acquire symptom information of the user by receiving a new symptom or side effect occurring after using the eyedrops and a symptom from the user.
  • the information acquisition unit 210 may obtain information about the user's use of eye drops for each eye drop.
  • the information acquisition unit 210 may receive information about the time the eyedrops were used and information about the reason for omitting the eyedrops from the user, and obtain information about the use of each eyedropper by the user.
  • the time information may include the date, day, and time of using the eyedrops.
  • reason information may include reasons such as lack of eye drops, occurrence of eye discomfort, going out, falling asleep, and the like.
  • the user management unit 220 may generate information on side effects and use pattern information according to use of eye drops by using information on use of each eye drop. Also, the user management unit 220 may generate customized information to be provided to the user based on at least one of the generated side effect information and usage pattern information. For example, the user management unit 220 may generate side effect information analyzed for each component of the eye drop based on eye drop information for each eye drop. For example, the user management unit 220 may match the generated side effect information with the user's symptom information to generate customized information as a result of determining whether side effects occur due to the use of eye drops.
  • the user management unit 220 may match the generated side effect information with the user's symptom information, and determine whether side effects occur due to the use of the eyedrops by using the matched degree and the number of matches. For another example, if the user management unit 220 determines that the side effects are due to the use of eye drops, determine a specific eye drop estimated to be the cause of the side effect from among at least one eye drop, and generate information about the specific eye drop as customized information. can In detail, the user management unit 220 may determine an eyedrop including a component generating side effect information that matches the user's symptom information as a specific eyedrop. Accordingly, the user management unit 220 may generate at least one of side effect information for each ingredient, information as a result of determining whether side effects occur due to use of eye drops, and information on a specific eye drop estimated to be a cause of side effects as customized information.
  • the user management unit 220 may periodically generate usage pattern information based on the user's usage information for each eyedrop collected for a certain period of time.
  • the user management unit 220 may create customized information as a result of evaluating whether or not to improve through a comparison between each use pattern information generated periodically. For example, the user management unit 220 extracts days and time slots in which eyedrop use is omitted from each periodically generated use pattern information and compares results of calculating a use ratio with each other to determine whether the user's eyedrop use pattern has improved.
  • the user management unit 220 extracts a specific repetitive reason based on the omission reason information included in the user's use information for each eye drop. can do.
  • the user management unit 220 may generate advice information corresponding to the extracted specific reason as customized information. Accordingly, the user management unit 220 may generate at least one of usage pattern information, information as a result of evaluating whether eyedrop usage patterns are improved, and advice information corresponding to a specific reason for repeated omission as customized information.
  • the notification information generating unit 230 may generate notification information for improving the user's use of eye drops based on side effect information or usage pattern information. For example, the notification information generation unit 230 may determine a use time point for each eye drop according to medication-taking guidance information generated based on eye drop information for each eye drop and an expected omission time point according to use pattern information. In addition, the notification information generation unit 230 may generate notification information to guide use of the eyedrops at a time of use for each eyedropper and a time point at which eyedrops are expected to be omitted.
  • the notification information generation unit 230 may determine a use time for each eye drop according to the frequency of use of the eye drop included in the eye drop information for each eye drop, and generate notification information to guide use of the eye drop at the time of use. For another example, the notification information generation unit 230 determines an omission point extracted from immediately preceding usage pattern information among periodically generated usage pattern information as an omission expected time point, and guides use of the eyedrops at the omission expected time point. Notification information can be created.
  • the notification information generation unit 230 may determine whether the additional time point for each eye drop determined based on the user's use information for each eye drop or the replacement time point for each eye drop determined based on the side effect information falls within a predetermined period. In addition, when the additional time point for each eyedropper or the replacement time point for each eyedropper falls within a predetermined period, the notification information generation unit 230 may generate notification information to guide a medical appointment in advance based on each point of time. For example, the notification information generating unit 230 may be configured to add eye drops before the eye drops are exhausted based on the number of eye drops included in the eye drop information for each eye drop and the number of times of use included in the use information for each eye drop. Additional time points can be determined. For another example, the notification information generation unit 230 may determine the necessity of eyedrop replacement based on the risk of side effects included in the side effect information, and determine the replacement timing for each eyedropper.
  • FIG. 3 is a flowchart illustrating an overall operation of generating customized information and notification information by the apparatus for supporting use of eye drops according to an embodiment of the present disclosure.
  • the information obtaining unit 210 of the apparatus for supporting the use of eye drops obtains at least one eye drop information for each eye drop used by a user, symptom information of the user, and use information for each eye drop of the user. It can be obtained (S310).
  • the information acquisition unit 210 may receive eye drop name information and eye drop number information from a user or extract them from a medical record of a user received from a server and obtain eye drop information for each eye drop.
  • the information acquisition unit 210 may obtain eye drop information for each eye drop, including ingredients, dosage and usage, effects, side effects, and interactions of the eye drop, based on the eye drop name information.
  • the information obtaining unit 210 may request a user to input new symptoms or side effects after using the eyedrops and input on the symptoms, and obtain the received symptoms as the user's symptom information.
  • the information acquisition unit 210 may obtain information about the user's use of each eyedrop by receiving information about a time when eyedrops were used and information about a reason for missing eyedrops from the user.
  • the user management unit 220 of the apparatus for supporting the use of eye drops may generate information on side effects and use pattern information according to the use of eye drops by using the use information for each eye drop (S320). For example, the user management unit 220 may generate side effect information by analyzing side effects that may occur for each component included in eye drops used by the user. For example, the user management unit 220 may generate a list of possible side effects for each ingredient included in each eyedrop used by the user as side effect information.
  • the user management unit 220 may periodically generate usage pattern information based on the user's usage information for each eyedrop collected for a certain period of time.
  • the cycle is described as an example of a week unit, but is not limited thereto.
  • the user management unit 220 may generate information on a user's use pattern by collecting eye drop use time for each eye drop and eye drop omission time for not using the eye drop.
  • the user management unit 220 may calculate a usage ratio for each eyedrop based on the number of omissions to the number of times the user prescribed eyedrops to use, thereby generating user usage pattern information.
  • the user management unit 220 may use the user's usage information for each eyedrop through a machine learning-based algorithm in at least one time zone and situation in which the user uses eyedrops, a time zone before bedtime, and an outing situation. By learning the pattern, it is possible to generate usage pattern information including an expected missing time point predicted based on the learned algorithm.
  • the user management unit 220 of the apparatus for supporting the use of eye drops may generate customized information to be provided to the user based on at least one of the generated side effect information and use pattern information (S330). For example, the user management unit 220 may generate customized information as a result of determining whether side effects occur due to the use of eyedrops by matching generated side effect information for each component with symptom information of the user. For example, the user management unit 220 may determine whether or not a side effect occurs due to the use of the eyedrops by matching generated side effect information for each component with symptom information of the user.
  • the user management unit 220 may determine a specific eyedrop that is presumed to be a cause of the side effect according to a matching result of side effect information for each component and symptom information of the user.
  • the user management unit 220 may determine a specific eyedrop that causes a side effect by using a machine learning-based algorithm. Specifically, the user management unit 220 learns using a machine learning-based algorithm and analyzes the side effect information for each ingredient included in the eyedrops and the side effect information for each patient based on the pre-learned data to determine the specific side effect that caused the user's side effect. You can decide on eye drops.
  • the machine learning-based algorithm may refer to an algorithm that enables a computer to solve a problem by itself through learning without a person directly inputting or instructing the computer a logic.
  • the user management unit 220 may generate customized information as a result of evaluating whether or not a usage pattern is improved through comparison between periodically generated usage pattern information. For example, the user management unit 220 may extract eyedrop usage time and eyedrop omission time from each usage pattern information, calculate a usage ratio for each eyedropper, evaluate whether the usage pattern is improved, and generate customized information. . For another example, the user management unit 220 may generate customized information by evaluating whether a usage pattern is improved using statistical data. Specifically, the user management unit 220 evaluates whether or not the usage pattern is improved using statistical data based on eyedrop usage time, eyedrop omission time, usage ratio for each eyedrop, etc. included in each usage pattern information to provide customized information. can create
  • the notification information generating unit 230 of the eyedrop use support device may generate notification information for improving the user's use of eyedrops based on side effect information or use pattern information (S340).
  • the notification information generation unit 230 may generate notification information to guide the user to use eyedrops.
  • the notification information generation unit 230 may determine the use time for each eyedrop using the number of times of taking the eyedrops as well as the medication-taking period according to the number of prescription days included in the eyedrop-taking guidance information.
  • the notification information generation unit 230 may determine an expected omission time point by extracting a time slot or situation in which eyedrop use is omitted from use pattern information including an eyedrop use time and an eyedrop omission time for each eyedropper.
  • the notification information generating unit 230 may generate notification information to guide a user to a medical appointment in advance. For example, the notification information generation unit 230 may determine an additional time point for each eyedrop, based on information on the number of eyedrops included in the eyedropper information for each eyedropper and usage count information included in the usage information for each eyedropper. For another example, the notification information generation unit 230 may determine a replacement time point for each eyedrop that needs to be replaced based on the risk of side effects included in the side effect information.
  • FIG. 4 is a flowchart illustrating an operation of generating and using side effect information by the apparatus for supporting use of eye drops according to an embodiment of the present disclosure.
  • the user management unit 220 of the apparatus for supporting the use of eye drops may generate side effect information by analyzing possible side effects for each component included in the eye drops used by the user (S410). ). For example, the user management unit 220 may classify ingredients included in each eye drop and generate a list of possible side effects for each ingredient as side effect information. Specifically, the user management unit 220 may quantify the risk of each side effect and generate side effect information. In addition, the user management unit 220 may generate side effect information based on specific ingredients or specific side effects for each eye drop so that each eye drop can be distinguished.
  • the user management unit 220 may match side effect information and user symptom information to determine whether or not a side effect occurs due to the use of eye drops (S420).
  • the user management unit 220 may match generated side effect information for each component with symptom information of the user, and determine whether side effects occur due to use of the eyedrops by using the matching degree and matching frequency.
  • the degree of matching may be determined based on whether the user's symptom matches a high-risk side effect.
  • the number of matches may be determined based on whether symptom information collected for a certain period of time is continuously matched.
  • the user management unit 220 may determine whether the user uses a plurality of eyedrops (S430). For example, the user management unit 220 may determine whether the user uses a single eyedrop or a plurality of eyedrops through eyedrop information for each eyedrop input from the user.
  • the user management unit 220 may determine a specific eye drop estimated to be a cause of side effects from among the plurality of eye drops (S440). For example, the user management unit 220 may determine the corresponding eye drop as a specific eye drop presumed to cause the side effect when the user's symptom coincides with a side effect caused by a component included in only one eye drop. Alternatively, when the user has several symptoms, the user management unit 220 may determine, in order, the eye drops that contain the most symptoms as the specific eye drops estimated to be the cause of side effects. For another example, the user management unit 220 may determine a specific eyedrop that causes a side effect by using a pre-learned machine learning-based algorithm, as shown in FIG. 3 described above.
  • the notification information generation unit 230 may determine whether to replace the eyedrops based on the determined specific eyedrops, and determine a replacement time point according to the determination result (S450). For example, the notification information generation unit 230 may determine whether or not to replace the eyedrops and when to replace the eyedrops according to the risk of side effects of the specific eyedrops matched with the user's symptom information. For example, if the user's symptom corresponds to a side effect with a high risk among side effects that may occur from a specific eye drop, the notification information generating unit 230 may determine that medical treatment is urgently needed to replace the eye drop.
  • the notification information generation unit 230 may determine that treatment is necessary for replacement of eye drops, but not urgent. Accordingly, the notification information generating unit 230 may generate notification information including a phrase or reservation schedule for guiding a medical appointment in advance based on a replacement time point for each eyedrop that is determined to be necessary through medical treatment.
  • FIG. 5 is a flowchart illustrating an operation of generating and using use pattern information by the apparatus for supporting use of eye drops according to an embodiment of the present disclosure.
  • the user management unit 220 of the apparatus for supporting the use of eye drops may periodically generate usage pattern information based on user information on each eye drop collected for a predetermined period (S510). ).
  • the user management unit 220 may generate information on a user's use pattern by collecting eye drop use time for each eye drop and eye drop omission time for not using the eye drop.
  • the usage pattern information may include a usage ratio for each eyedrop that is calculated based on the number of omissions of the number of times the user prescribed eyedrops are used.
  • the user management unit 220 may evaluate whether or not to improve through a comparison between each periodically generated usage pattern information (S520). For example, the user management unit 220 may evaluate that the user's usage pattern is improved if the number of omissions of the generated usage pattern information is reduced or the usage ratio for each eye drop is increased compared to the immediately preceding usage pattern information. For another example, the user management unit 220 may evaluate whether or not the usage pattern is improved by using statistical data on each usage pattern information, as shown in FIG. 3 described above.
  • the user management unit 220 may determine whether the user's use of the eyedrops is repeatedly omitted based on the usage pattern information (S530). For example, the user management unit 220 may determine whether omission repeatedly occurs in a specific time period or continuous omission occurs from a specific point in time based on usage pattern information.
  • the user management unit 220 may extract a specific reason for repetition and generate advice information (S540). For example, the user management unit 220 may generate advice information corresponding to a specific recurring reason among omission reason information when it is determined that the user's use of eyedrops is repeatedly omitted. Specifically, when a specific reason is lack of eyedrops, advice information to periodically check the number of eyedrops may be generated. Alternatively, when a specific cause is eye discomfort and the corresponding reason occurs more than a specific number of times, advice information indicating that medical treatment is required to replace eye drops may be generated.
  • advice information to carry extra eyedrops may be generated based on the user's location.
  • advice information to be used after dinner or in conjunction with other regular lifestyles may be generated.
  • the notification information generating unit 230 may determine a use time point for each eyedrop based on the medication guidance information and may determine an expected omission time point based on the use pattern information (S550). For example, the notification information generating unit 230 may determine a predetermined time during the medication-taking period for each eyedrop as the use time point for each eyedrop based on the medication guidance information for each eyedrop, which is generated based on the eyedrop for each eyedrop. In addition, the notification information generating unit 230 may receive an input from a user and determine a preset time as a use time point for each eye drop.
  • the notification information generating unit 230 may extract a time point at which the user's use of the eyedrops is omitted from immediately preceding usage pattern information among periodically generated usage pattern information, and determine the time point as the expected omission time point.
  • the notification information generation unit 230 may determine the missing expected timing included in the usage pattern information predicted based on the learned algorithm. Accordingly, the notification information generating unit 230 may generate notification information including a phrase guiding the use of the eyedrops based on the use time of each eyedrop and the expected time of omission.
  • the notification information for guiding the use of the eyedrops may be generated in the form of at least one of a visual signal, an auditory signal, and a vibration signal.
  • FIG. 6 is a flowchart of a method for supporting use of eye drops according to an embodiment of the present disclosure.
  • the method for supporting the use of eye drops includes an information acquisition step of obtaining at least one eye drop information for each eye drop used by a user, symptom information of the user, and use information for each eye drop of the user. It can (S610).
  • the eyedrop use support device may obtain eyedrop-specific eyedrop information for at least one eyedrop used by the user.
  • the apparatus for supporting use of eye drops may receive eye drop name information and eye drop number information from a user and obtain eye drop information for each eye drop.
  • the eyedrop use support device may obtain eyedrop information for each eyedrop by automatically extracting eyedrop name information and eyedrop number information from the user's medical record received from the server.
  • the eye drop information for each eye drop may include information on ingredients, dosage and usage, effects, side effects, interactions, and the like of the eye drop.
  • the apparatus for supporting the use of eye drops may obtain symptom information of the user regarding symptoms occurring after the user uses the eye drops.
  • the apparatus for supporting the use of eye drops may acquire symptom information of the user by receiving a new symptom or side effect occurring after using the eye drop and a symptom from the user.
  • the apparatus for supporting the use of eye drops may obtain information about the user's use of eye drops for each eye drop.
  • the eyedrop use support apparatus may receive information about a time when the eyedrops were used and information about a reason for missing the eyedrops from the user, and obtain information about the user's use of each eyedrop.
  • the method for supporting the use of eye drops may include a user management step of generating side effect information and use pattern information according to the use of eye drops, and generating customized information to be provided to the user (S620).
  • the apparatus for supporting use of eye drops may generate side effect information and usage pattern information according to the use of eye drops by using the use information for each eye drop.
  • the eyedrop use support device may generate customized information to be provided to the user based on at least one of the generated side effect information and use pattern information.
  • the apparatus for supporting the use of eye drops may match generated side effect information with information about a user's symptom to generate customized information as a result of determining whether a side effect occurs due to the use of eye drops.
  • the apparatus for supporting use of eye drops may determine a specific eye drop estimated to be the cause of the side effect from among at least one eye drop, and generate information about the specific eye drop as customized information.
  • the apparatus for supporting use of eye drops may determine an eye drop including an ingredient generating side effect information matched with symptom information of the user as a specific eye drop estimated to be a cause of the side effect.
  • the eyedrop use support device may periodically generate usage pattern information based on user's eyedrop use information collected for a predetermined period of time.
  • the eyedrop use support device may generate customized information as a result of evaluating improvement through comparison between each use pattern information generated periodically. For example, the eyedrop use support device may extract days and times during which eyedrop use is omitted from each periodically generated use pattern information and calculate a use rate.
  • the eyedrop use support device may evaluate whether or not the user's eyedrop use pattern is improved by periodically comparing each generated use pattern information with each other.
  • the apparatus for supporting use of eye drops extracts a specific reason for repetition based on reason information for omission included in the user's use information for each eye drop.
  • the eyedrop use support device may generate advice information corresponding to the extracted specific reason as customized information.
  • the method for supporting the use of eye drops may include a notification information generation step of generating notification information for improving the user's use of eye drops based on side effect information or use pattern information (S620).
  • the eyedrop use support device may determine a use time point for each eye drop according to medication-taking guidance information generated based on eye drop information for each eye drop and an expected omission time point according to use pattern information.
  • the eyedrop use support device may generate notification information to guide the use of the eyedrops at a time of use for each eyedropper and a time point at which eyedrops are expected to be omitted.
  • the apparatus for supporting use of eye drops may determine a use time for each eye drop according to the frequency of use of the eye drop included in the eye drop information for each eye drop, and generate notification information to guide use of the eye drop at the time of use.
  • the eyedrop use support device determines an omission point extracted from immediately preceding use pattern information as an expected omission point among periodically generated use pattern information, and provides additional notification information to guide the use of eyedrops at the expected point in time. can create
  • the apparatus for supporting use of eye drops may determine whether the additional time point for each eye drop determined based on the user's use information for each eye drop or the replacement time point for each eye drop determined based on the side effect information falls within a predetermined period.
  • notification information may be generated to guide a medical appointment in advance based on each time point.
  • the eyedrop use support device determines an additional time point for each eyedrop so that eyedrops can be added before the eyedrops are exhausted based on information on the number of eyedrops included in the information on the number of eyedrops included in the information on the use of each eyedrop and information on the number of uses included in the information on the use of each eyedrop. can decide
  • the apparatus for assisting use of eye drops may determine the need to replace the eye drops based on the risk of side effects included in the side effect information, and determine the replacement timing for each eye drop.
  • FIG. 7 is a diagram conceptually illustrating the configuration of a recording medium according to an embodiment of the present disclosure.
  • the recording medium 700 recording a program for executing the method for supporting the use of eye drops is obtained information for obtaining at least one eye drop information for each eye drop used by a user, symptom information of the user, and use information for each eye drop used by the user.
  • It may include a user management function 720 and a notification information generation function 730 for generating notification information for improving the user's use of eye drops based on side effect information or usage pattern information.
  • the information acquisition function 710 may obtain at least one eyedrop information for each eyedrop used by the user, symptom information of the user, and usage information for each eyedropper of the user.
  • the information acquisition function 710 may acquire eyedrop name information and eyedrop number information input from the user as eyedropper-specific eyedropper information.
  • the information acquisition function 710 may obtain information about symptoms generated after use of the eyedrops received from the user as the user's symptom information.
  • the information acquisition function 710 may acquire use time information and omission reason information of the eye drops input from the user as use information for each eye drop of the user.
  • the user management function 720 may generate information on side effects and use pattern information according to use of eye drops by using information on use of each eye drop.
  • the user management function 720 may generate customized information to be provided to the user based on at least one of the generated side effect information and usage pattern information.
  • the user management function 720 may generate side effect information analyzed for each component of eye drops based on eye drop information for each eye drop.
  • the user management function 720 may match the generated side effect information with the user's symptom information to generate customized information as a result of determining whether side effects occur due to the use of eye drops.
  • the user management function 720 determines a specific eye drop estimated to be the cause of the side effect from among at least one eye drop, and generates information about the specific eye drop as customized information. .
  • the user management function 720 may periodically generate usage pattern information based on user's usage information for each eyedrop collected for a predetermined period of time.
  • the user management function 720 may create customized information as a result of evaluating whether or not to improve through a comparison between periodically generated usage pattern information.
  • the user management function 720 may evaluate whether or not improvement is achieved by extracting days and time slots in which the use of eyedrops is omitted from each usage pattern information and calculating a usage ratio.
  • the advice information corresponding to the repeated specific reason extracted based on the reason for omission included in the user's use information for each eyedropper is provided. can be created with customized information.
  • the notification information generating function 730 may generate notification information for improving the user's use of eye drops based on side effect information or use pattern information. For example, the notification information generation function 730 determines the use time for each eye drop according to the medication guidance information generated based on the eye drop information for each eye drop and the expected omission time according to the usage pattern information to prevent the use of the eye drop at each time point. Notification information may be generated to guide. For another example, the notification information generation function 730 may perform the addition time for each eye drop determined based on the user's usage information for each eye drop or the replacement time for each eye drop determined based on the side effect information within a certain period of time, based on each time point. It is possible to generate notification information to guide a medical appointment in advance.
  • the above-described method for supporting use of eye drops according to an embodiment of the present disclosure is implemented as an application (ie, a program) basically installed in the apparatus 100 for supporting use of eye drops or directly installed by a user, and It can be recorded on a computer-readable recording medium.
  • a program implementing the method for supporting the use of eye drops according to an embodiment of the present disclosure executes an information acquisition function, a user management function, a notification information generation function, and the like. These programs can be recorded on a computer-readable recording medium and executed by a computer to execute the aforementioned functions.
  • the above-described program is C, C++, JAVA, machine language, etc. that can be read by the computer's processor (CPU) It may include a code coded in a computer language.
  • These codes may include functional codes related to functions defining the above-described functions, and may include control codes related to execution procedures necessary for a processor of a computer to execute the above-described functions according to a predetermined procedure.
  • these codes may further include memory reference related codes for which location (address address) of the computer's internal or external memory should be referenced for additional information or media necessary for the computer's processor to execute the above-mentioned functions. .
  • the code is used by the computer processor to communicate with the computer's communication module (e.g., wired and/or wireless communication module). ) may further include communication-related codes for how to communicate with any other remote computer or server, and what information or media should be transmitted/received during communication.
  • the computer's communication module e.g., wired and/or wireless communication module.
  • a functional program for implementing the present disclosure codes and code segments related thereto, in consideration of the system environment of a computer that reads a recording medium and executes a program, etc. It may be easily inferred or changed by
  • the computer-readable recording medium on which the above-described program is recorded is distributed to computer systems connected through a network, so that computer-readable codes can be stored and executed in a distributed manner.
  • any one or more computers among the plurality of distributed computers may execute some of the functions presented above, transmit the execution results to one or more of the other distributed computers, and receive the transmitted results.
  • a computer may also execute some of the functions presented above and provide the results to other distributed computers as well.
  • the computer-readable recording medium in which the program for executing the eyedrop use support method according to the embodiment of the present disclosure is recorded for example, ROM, RAM, CD-ROM, magnetic tape, floppy disk , optical media storage devices, and the like.
  • a computer-readable recording medium on which an application, which is a program for executing the method for supporting use of eye drops according to an embodiment of the present disclosure, is recorded an application store server (Application Store Server), an application or a web server (Web server) related to the corresponding service It may be a storage medium (eg, hard disk, etc.) included in an application providing server (Application Provider Server) including a server), the application providing server itself, or another computer on which a program is recorded or its storage medium.
  • Application Store Server Application Store Server
  • Web server web server
  • a general PC such as a general desktop or laptop computer
  • a smart phone such as a tablet PC
  • PDA personal digital assistants and mobile communication terminals
  • a mobile device such as a smart phone, a tablet PC, a PDA (Personal Digital Assistants), and a mobile communication terminal may be used.
  • the mobile terminal may download and install the corresponding application from an application providing server including an application store server, web server, etc.
  • an application providing server including an application store server, web server, etc.
  • a synchronization program After being downloaded from the application providing server to a general PC, through a synchronization program. It may also be installed in a mobile terminal.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioethics (AREA)
  • Anesthesiology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

La présente divulgation concerne un dispositif, un procédé, et un support d'enregistrement pour prendre en charge l'utilisation de gouttes ophtalmiques et peut concerner un dispositif, un procédé, et un support d'enregistrement pour prendre en charge l'utilisation de gouttes ophtalmiques. Selon l'invention, lorsqu'un utilisateur utilise au moins une goutte ophtalmique, des informations sur des effets secondaires concernant l'utilisation de la goutte ophtalmique et des informations de modèle d'utilisation sont produites pour prendre en charge l'utilisation de la goutte ophtalmique par l'utilisateur. En particulier, les informations de modèles d'utilisation concernant le modèle d'utilisation de gouttes ophtalmiques de l'utilisateur sont fournies par l'intermédiaire d'un avis et on évalue si une amélioration se produit ou non, ce qui permet de fournir un dispositif, un procédé et un support d'enregistrement pour prendre en charge l'utilisation de gouttes ophtalmiques, qui aident l'utilisateur à utiliser des gouttes ophtalmiques.
PCT/KR2022/012571 2021-09-01 2022-08-23 Dispositif, procédé et support d'enregistrement d'aide à l'utilisation de gouttes oculaires Ceased WO2023033434A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020210116151A KR20230033323A (ko) 2021-09-01 2021-09-01 안약 사용 지원 장치, 방법 및 기록매체
KR10-2021-0116151 2021-09-01

Publications (1)

Publication Number Publication Date
WO2023033434A1 true WO2023033434A1 (fr) 2023-03-09

Family

ID=85412837

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2022/012571 Ceased WO2023033434A1 (fr) 2021-09-01 2022-08-23 Dispositif, procédé et support d'enregistrement d'aide à l'utilisation de gouttes oculaires

Country Status (2)

Country Link
KR (1) KR20230033323A (fr)
WO (1) WO2023033434A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102880193B1 (ko) * 2023-06-15 2025-11-03 가톨릭대학교 산학협력단 사물 인터넷을 접목한 스마트 안대, 그 동작 제어 방법 및 시스템

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010082125A (ja) * 2008-09-30 2010-04-15 Higashi Nihon Medicom Kk 携帯端末機器による服薬管理システム
KR20170087299A (ko) * 2016-01-20 2017-07-28 동국대학교 산학협력단 스마트 기기를 이용한 맞춤형 약 복용 정보 서비스 제공 방법
KR20180038905A (ko) * 2016-10-07 2018-04-17 김성진 약물간 부작용 및 복용시간 알림 장치
KR20200083806A (ko) * 2018-12-28 2020-07-09 충북대학교병원 성분명 기반 알레르기 위험도 평가 방법
KR20210057423A (ko) * 2019-11-12 2021-05-21 주식회사 머니업 사용자 맞춤형 의료 정보를 제공하기 위한 방법 및 장치

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010082125A (ja) * 2008-09-30 2010-04-15 Higashi Nihon Medicom Kk 携帯端末機器による服薬管理システム
KR20170087299A (ko) * 2016-01-20 2017-07-28 동국대학교 산학협력단 스마트 기기를 이용한 맞춤형 약 복용 정보 서비스 제공 방법
KR20180038905A (ko) * 2016-10-07 2018-04-17 김성진 약물간 부작용 및 복용시간 알림 장치
KR20200083806A (ko) * 2018-12-28 2020-07-09 충북대학교병원 성분명 기반 알레르기 위험도 평가 방법
KR20210057423A (ko) * 2019-11-12 2021-05-21 주식회사 머니업 사용자 맞춤형 의료 정보를 제공하기 위한 방법 및 장치

Also Published As

Publication number Publication date
KR20230033323A (ko) 2023-03-08

Similar Documents

Publication Publication Date Title
WO2015008936A1 (fr) Appareil de diagnostic à l'aide d'habitudes, appareil de gestion du diagnostic et procédé de diagnostic l'utilisant.
WO2022169037A1 (fr) Procédé pour prédire la santé mentale et fournir des solutions de santé mentale par apprentissage de données d'indicateur psychologique et de données d'indicateur physique sur la base d'un apprentissage automatique, et dispositif d'évaluation de santé mentale l'utilisant
US20060122469A1 (en) Remote medical monitoring system
WO2015199296A1 (fr) Système et procédé de psychiatrie d'urgence à distance basée sur un modèle de prédiction d'état mental psychiatrique d'urgence
WO2024090713A1 (fr) Système de gestion de psychologie d'utilisateur par l'intermédiaire d'un service de robot conversationnel basé sur la psychologie empathique
WO2014209006A1 (fr) Dispositif et procédé de modélisation personnalisée du style de vie
WO2023033434A1 (fr) Dispositif, procédé et support d'enregistrement d'aide à l'utilisation de gouttes oculaires
WO2021072208A1 (fr) Système et procédé pour surveiller la conformité d'un système avec des mesures visant à améliorer l'état d'un système
WO2025225795A1 (fr) Système pour fournir un assistant conversationnel de conseil basé sur l'intelligence artificielle
EP3108378A1 (fr) Création d'une mémoire épisodique sur la base de données non structurées dans des dispositifs électroniques
WO2021236520A1 (fr) Procédé et système de détection de déchets, de fraudes et d'abus dans un accès aux informations à l'aide d'une intelligence artificielle cognitive
WO2020153715A1 (fr) Dispositif électronique et procédé de commande du dispositif électronique
WO2020005016A1 (fr) Procédé et système de réalisation d'une enquête relatif à la miction, et support d'enregistrement lisible par ordinateur non transitoire
JP2012027726A (ja) 患者情報管理装置、患者情報管理プログラム及び患者情報管理方法
WO2021112317A1 (fr) Système et procédé de prédiction de santé utilisant un dispositif d'analyse de micro-organisme buccal
US20220093274A1 (en) Integrated contact tracing platform
WO2023038363A1 (fr) Appareil de diagnostic de la rhinite, procédé et support d'enregistrement
WO2024071595A1 (fr) Procédé et dispositif de détection de médicament à effets secondaires et de fourniture de médicament optimisé à l'aide de données personnalisées sur les effets secondaires
EP4033498A1 (fr) Système et procédé d'augmentation de données vidéo
WO2022031025A1 (fr) Appareil numérique et application pour traiter le trouble de la communication sociale
WO2023229191A1 (fr) Procédé et appareil de diagnostic d'une maladie à distance
Paganelli et al. A context-aware service platform to support continuous care networks for home-based assistance
EP3588507B1 (fr) Surveillance à distance des mesures dans des essais cliniques
WO2023018241A1 (fr) Dispositif de gestion de globe oculaire, procédé et support d'enregistrement
Das Towards Developing a Mobile-Based Care for Children With ASD Using Remote Experience Sampling Method (mCARE)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22864937

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 22864937

Country of ref document: EP

Kind code of ref document: A1